US Stock MarketDetailed Quotes
CPIX Cumberland Pharmaceuticals
- 1.041
- -0.019-1.78%
Trading Nov 25 10:26 ET
14.62MMarket Cap-1368P/E (TTM)
1.115High1.040Low6.54KVolume1.040Open1.060Pre Close6.94KTurnover0.08%Turnover RatioLossP/E (Static)14.04MShares2.35952wk High0.59P/B8.18MFloat Cap1.04052wk Low--Dividend TTM7.86MShs Float17.750Historical High--Div YieldTTM7.08%Amplitude1.040Historical Low1.061Avg Price1Lot Size
Cumberland Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.92%9.09M | -9.55%9.85M | -7.88%8.5M | -5.85%39.55M | 2.51%9.35M | -11.63%10.09M | 5.73%10.89M | -17.45%9.22M | 16.75%42.01M | 9.66%9.12M |
| Operating revenue | -13.54%8.46M | -9.55%9.85M | -7.88%8.5M | -7.79%37.51M | 16.84%9.11M | -14.25%9.79M | 5.73%10.89M | -17.45%9.22M | 16.08%40.68M | 5.61%7.79M |
| Cost of revenue | -25.07%1.32M | 12.50%1.71M | 26.02%1.58M | -33.47%6.07M | -42.27%1.53M | -20.63%1.77M | -25.15%1.52M | -43.48%1.25M | 3.49%9.12M | -20.30%2.65M |
| Gross profit | -6.70%7.76M | -13.13%8.14M | -13.19%6.92M | 1.80%33.49M | 20.85%7.82M | -9.45%8.32M | 13.32%9.37M | -11.03%7.97M | 21.04%32.89M | 29.61%6.47M |
| Operating expense | -7.16%9.46M | -1.93%9.16M | -7.52%8.79M | 11.51%43.04M | 60.01%14M | 7.49%10.19M | -7.60%9.35M | -7.30%9.51M | 10.75%38.6M | -6.39%8.75M |
| Selling and administrative expenses | -0.20%7.07M | -0.52%7.01M | -3.75%6.52M | 8.43%29.1M | 19.04%8.2M | 12.91%7.09M | 4.16%7.04M | -2.03%6.78M | 8.25%26.84M | 2.51%6.89M |
| -Selling and marketing expense | -7.29%4.4M | -9.07%4.25M | -2.87%4.15M | 10.75%18.45M | 40.83%4.76M | 15.39%4.74M | 2.53%4.67M | -7.31%4.28M | 10.96%16.66M | 2.22%3.38M |
| -General and administrative expense | 14.14%2.68M | 16.34%2.76M | -5.25%2.37M | 4.63%10.65M | -1.95%3.44M | 8.21%2.34M | 7.53%2.37M | 8.54%2.5M | 4.09%10.18M | 2.79%3.51M |
| Research and development costs | -32.14%1.31M | -7.50%1.06M | -22.77%1.16M | -12.78%5.83M | -10.04%1.26M | 12.28%1.92M | -37.21%1.15M | -14.07%1.5M | 17.67%6.69M | -12.83%1.41M |
| Depreciation amortization depletion | -8.24%1.08M | -5.04%1.1M | -9.71%1.11M | 59.90%8.1M | 890.60%4.54M | -20.94%1.18M | -24.27%1.16M | -22.79%1.23M | 15.92%5.07M | -54.95%458.22K |
| -Depreciation and amortization | -8.24%1.08M | -5.04%1.1M | -9.71%1.11M | 59.90%8.1M | 890.60%4.54M | -20.94%1.18M | -24.27%1.16M | -22.79%1.23M | 15.92%5.07M | -54.95%458.22K |
| Operating profit | 9.22%-1.69M | -4,591.40%-1.03M | -22.04%-1.87M | -67.48%-9.55M | -171.28%-6.18M | -546.81%-1.87M | 101.24%22.86K | -18.55%-1.53M | 25.69%-5.7M | 47.68%-2.28M |
| Net non-operating interest income expense | -494.04%-68.18K | 52.42%-64.51K | 84.00%-21.78K | 21.86%-381.01K | 26.89%-97.79K | 91.01%-11.48K | -10.62%-135.57K | -31.52%-136.16K | -577.68%-487.59K | -535.02%-133.76K |
| Non-operating interest income | -29.83%69.19K | 8.38%61.84K | 92.76%96.75K | 191.50%286.85K | 77.26%81K | 356.45%98.6K | 278.74%57.06K | 212.89%50.19K | 277.31%98.41K | 585.10%45.7K |
| Non-operating interest expense | 24.79%137.37K | -34.41%126.35K | -36.40%118.53K | 13.97%667.86K | -0.37%178.79K | -26.29%110.08K | 39.97%192.64K | 55.85%186.35K | 497.76%586K | 547.06%179.46K |
| Other net income (expense) | -71.15%237.09K | 497.17%3.65M | 0 | 821.8K | 60.60%981.81K | 1.85M | -72.05%611.33K | 0 | ||
| Special income (charges) | -71.15%237.09K | ---- | ---- | 34.43%821.8K | --0 | --821.8K | ---- | ---- | --611.33K | --0 |
| -Less:Other special charges | 71.15%-237.09K | ---- | ---- | -34.43%-821.8K | --0 | ---821.8K | ---- | ---- | ---611.33K | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---- | --2.83M | --0 | ---- | --981.81K | --1.85M | ---- | ---- |
| Income before tax | -44.42%-1.53M | -225.56%-1.09M | -1,155.12%-1.89M | -12.61%-6.28M | -160.29%-6.28M | -153.71%-1.06M | 164.01%869.09K | 112.84%179.22K | -0.34%-5.58M | 44.88%-2.41M |
| Income tax | 64.92%11.44K | 64.96%11.44K | 64.92%11.44K | -33.52%45.77K | -48.17%24.96K | 0.55%6.94K | 0.54%6.94K | 0.55%6.94K | 97.33%68.85K | 284.71%48.15K |
| Net income | -44.56%-1.54M | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K | -56.82%-5.65M | 36.67%-2.46M |
| Net income continuous Operations | -44.56%-1.54M | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K | -0.95%-5.65M | 43.94%-2.46M |
| Minority interest income | 151.09%7.11K | -69.47%-17.03K | 320.08%43.79K | 35.53%-51.45K | 60.07%-7.58K | 4.57%-13.92K | 65.41%-10.05K | -15.82%-19.9K | 16.19%-79.8K | 48.07%-18.99K |
| Net income attributable to the parent company | -47.15%-1.54M | -224.47%-1.09M | -1,112.71%-1.95M | -12.73%-6.28M | -157.89%-6.29M | -156.78%-1.05M | 165.30%872.2K | 113.87%192.18K | -58.81%-5.57M | 36.57%-2.44M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -47.15%-1.54M | -224.47%-1.09M | -1,112.71%-1.95M | -12.73%-6.28M | -157.89%-6.29M | -156.78%-1.05M | 165.30%872.2K | 113.87%192.18K | -58.81%-5.57M | 36.57%-2.44M |
| Basic earnings per share | -57.14%-0.11 | -233.33%-0.08 | -1,500.00%-0.14 | -15.79%-0.44 | -158.82%-0.44 | -133.33%-0.07 | 166.67%0.06 | 111.11%0.01 | -58.33%-0.38 | 34.62%-0.17 |
| Diluted earnings per share | -57.14%-0.11 | -233.33%-0.08 | -1,500.00%-0.14 | -15.79%-0.44 | -158.82%-0.44 | -133.33%-0.07 | 166.67%0.06 | 111.11%0.01 | -58.33%-0.38 | 34.62%-0.17 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
